Track topics on Twitter Track topics that are important to you
The firm currently has a $74.00 price objective on the stock. Cowen's target price points to a potential upside of 18.61% from the stock's previous close.
In this episode of PharmaTelevision News Review, filmed at AusBio 2012 in Melbourne, Australia, Fintan Walton talks to George Millstien, Managing Director at Cowen
New York - Incyte-Aktienanalyse des Analysten Eric Schmidt von Cowen and Company: Aktienanalyst Eric Schmidt von Cowen and Company rechnet laut einer Aktienanalyse in Bezug auf die Aktien des US-bi...
Analysts at Cowen & Co. Reiterate their Buy rating for PVH with $165.0 PT; Pharmerica Sentiment Is 0 PharMerica Corporation operates as an institutional pharmacy services firm in the United States...
Cowen Research’s biotech team published a recent report and concluded that investors would have better luck ignoring—or even doing the complete opposite—of what equity analysts advise.
New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Analyst Phil Nadeau von Cowen and Company: Phil Nadeau, Aktienanalyst von Cowen and Company, rechnet laut einer Aktienanalys...
New York - Cisco Systems-Aktienanalyse von Analyst Paul Silverstein von Cowen and Company: Paul Silverstein, Aktienanalyst vom Investmenthaus Cowen and Company, rechnet bei den Aktien von Cisco Sys...
New York - General Electric-Aktienanalyse von Analyst Gautam Khanna von Cowen and Company: Laut einer aktuellen Aktienanalyse erwartet Analyst Gautam Khanna von Cowen and Company im Hinblick auf di...
Cowen and Keltner (2017) published the latest installment in a longstanding debate about whether measures of emotion organize themselves into categories or array themselves more continuously along aff...
Cowen Inc. is a diversified financial services firm and, together with its consolidated subsidiaries, provides alternative asset management, investment banking, research, sales an...
Cowen Group, Inc. is a diversified financial services firm and, together with its consolidated subsidiaries, provides alternative asset management, investment banking, research, a...
Cowen Group, Inc. is a leading diversified financial services firm providing alternative investment management, investment banking, research, and sales and trading services through its business units,...
Cowen Healthcare Royalty Partners is a global healthcare private equity firm that invests principally in commercial-stage biopharmaceutical and medical device companies and products, through the purch...
Cowen and Company's success and growth during the past decade of tumultuous consolidation and change in investment banking is a result of the power of our focus. The company’s foundation of unsurpas...
We have published hundreds of Cowen Inc. news stories on BioPortfolio along with dozens of Cowen Inc. Clinical Trials and PubMed Articles about Cowen Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cowen Inc. Companies in our database. You can also find out about relevant Cowen Inc. Drugs and Medications on this site too.
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...